Mechanical ventilation is an essential component of intensive care, providing necessary respiratory support for critically ill patients. However, determining the most suitable ventilator settings remains a complex process, as clinicians must balance adequate gas exchange against the risks of ventilator-induced lung injury and diaphragm dysfunction.
Clinicians must continuously reassess and adjust ventilator settings as patients’ physiological conditions evolve. Artificial intelligence (AI) may offer new opportunities to support these decisions through personalised, data-driven recommendations.
A study published in the Journal of Intensive Care in October 2026 investigated the development and validation of VentPilot, an AI-based recommendation system designed to optimise mechanical ventilation. Researchers from South Korea and the United States developed the system using offline reinforcement learning, incorporating high-resolution physiological data, ventilator parameters, and expert clinical feedback.
The objective was to determine whether VentPilot could generate recommendations associated with better clinical outcomes than observed conventional ventilator management. Unlike traditional rule-based automated ventilation systems, VentPilot was designed to learn from extensive clinical datasets and identify treatment strategies associated with favourable outcomes.
The international multicentre retrospective study included 4,296 mechanically ventilated adults. The researchers used two complementary evaluation methods, including fitted Q-evaluation and a comparison of clinical outcomes among patients whose actual ventilator settings showed greater or lesser agreement with VentPilot’s recommendations.
Read Also: Low-kVp CT Reduces Dose While Maintaining Image Quality
VentPilot demonstrated encouraging performance in both validation cohorts, with estimated differences of 1.6 points in the internal validation cohort and 1.3 points in the external validation cohort. Greater agreement between actual ventilator management and VentPilot recommendations was also associated with more ventilator-free days.
In the internal validation cohort, patients receiving care more closely aligned with VentPilot’s recommendations had an average of 17.2 ventilator-free days compared with 12.2 days among those with lower agreement. Similarly, in the external validation cohort, the corresponding figures were 17.9 and 14.9 days.
Additional analyses identified associations with shorter ventilation duration, reduced ICU length of stay, and lower 28-day mortality. In the internal validation cohort, mortality was 28.5% among patients whose management more closely matched VentPilot recommendations, compared with 41.7% among those with lower agreement. Corresponding mortality rates in the external validation cohort were 26.2% and 37.7%. Although these findings were encouraging, they represented observational associations rather than evidence that VentPilot itself reduced mortality.
Despite its promising findings, the study had important limitations, including the retrospective evaluation of VentPilot and the potential for residual confounding and differences in clinical practice. The system’s safety, usability, and performance during real-time clinical decision-making remain untested.
Prospective randomised trials will be essential to determine whether the theoretical and observational advantages of VentPilot translate into safer ventilation, shorter respiratory support, and improved patient outcomes. VentPilot represents an important development in AI-assisted critical care, offering a potential approach to managing the complexity of mechanical ventilation.
